These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 15617457)

  • 1. Sustained blood pressure-lowering effect of aliskiren compared with telmisartan after a single missed dose.
    Düsing R; Brunel P; Baek I; Baschiera F
    J Clin Hypertens (Greenwich); 2013 Jan; 15(1):41-7. PubMed ID: 23282123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk patients benefit most from nifedipine GITS-telmisartan combination.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(4):235. PubMed ID: 20838729
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of effects of telmisartan versus valsartan on post-induction hypotension during noncardiac surgery: a prospective observational study.
    Oh CS; Park JY; Kim SH
    Korean J Anesthesiol; 2024 Jun; 77(3):335-344. PubMed ID: 38311886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Telmisartan chronotherapy and its influence on the indicators of the daily profile blood pressure.].
    Agarkov NM; Osipova OA; Kopylov AE; Korovin EN; Titov AA; Shmarova DR; Alymova MV
    Adv Gerontol; 2023; 36(5):654-660. PubMed ID: 38180364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of orally administered telmisartan for the reduction of indirect systolic arterial blood pressure in awake, clinically normal cats.
    Coleman AE; Brown SA; Stark M; Bryson L; Zimmerman A; Zimmering T; Traas AM
    J Feline Med Surg; 2019 Feb; 21(2):109-114. PubMed ID: 29513155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach.
    Kumar U; Aich J; Devarajan S
    Anticancer Drugs; 2023 Nov; 34(10):1094-1103. PubMed ID: 36847075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of telmisartan and atenolol in management of essential hypertension.
    Khan P; Khan W; Abbasi A; Ahad A; Khan M; Ahmad Y; Ahmad A
    J Ayub Med Coll Abbottabad; 2012; 24(3-4):36-8. PubMed ID: 24669604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study.
    Kalikar M; Nivangune KS; Dakhale GN; Bajait CS; Sontakke SD; Motghare VM; Budania R
    J Pharmacol Pharmacother; 2017; 8(3):106-111. PubMed ID: 29081617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
    Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
    J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients.
    Lee YT; Lee CM; Lin CS; Sheu SH; Kuo WK; Tsai CW; Huang LC; Huang HC; Wang JS; Tseng WK
    Int J Clin Pract Suppl; 2004 Dec; (145):40-5. PubMed ID: 15617458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New standards in hypertension and cardiovascular risk management: focus on telmisartan.
    Galzerano D; Capogrosso C; Di Michele S; Galzerano A; Paparello P; Lama D; Gaudio C
    Vasc Health Risk Manag; 2010 Mar; 6():113-33. PubMed ID: 20448797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study.
    Zhu JR; Bai J; Cai NS; Tang B; Fan WH; Guo JZ; Ke YN; Guo JX; Sheng LH; Lu ZY; Cheng NN
    Int J Clin Pract Suppl; 2004 Dec; (145):46-9. PubMed ID: 15617459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study.
    Alcocer L; Fernandez-Bonetti P; Campos E; Dominguez-Henkel R; de la Fuente JJ; Segovia-Ayala C
    Int J Clin Pract Suppl; 2004 Dec; (145):23-8. PubMed ID: 15617455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: a multicentre, double-blind study in Taiwanese patients.
    Chen JH; Cheng JJ; Chen CY; Chiou HC; Huang TY; Tsai CD; Fu MM; Cherng WJ
    Int J Clin Pract Suppl; 2004 Dec; (145):29-34. PubMed ID: 15617456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach.
    Nixon RM; Müller E; Lowy A; Falvey H
    Int J Clin Pract; 2009 May; 63(5):766-75. PubMed ID: 19392925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan: a review of its use in hypertension.
    Sharpe M; Jarvis B; Goa KL
    Drugs; 2001; 61(10):1501-29. PubMed ID: 11558835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension.
    Alcocer L; Fernández-Bonetti P; Campos E; Olvera Ruiz R; Bahena J; de la Fuente JJ; Segovia-Ayala C; Dominguez-Henkel R
    Int J Clin Pract Suppl; 2004 Dec; (145):35-9. PubMed ID: 15617457
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.